Bibliografia

1. Sandireddy R, Yerra VG, Areti A, Komirishetty P, Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol. 2014; 2014: ID 674987.
2. Siemoneit U, Koeberle A, Rossi A, et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br J Pharmacol 2011; 162(1): 147-62.
3. Naik AK, Tandan SK, Dudhgaonkar SP, et al. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur J Pain 2006; 10(7): 573-9.
4. Ernst E. Frankincense: systematic review. BMJ 2008; 337: a2813.
5. Hermann R, Mungo J, Cnota PJ, Ziegler D. Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms. Clin Pharmacol 2014; 6: 195-204.
6. Memeo A, Loiero M. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized,double-blind, comparative study. Clin Drug Investig 2008; 28: 495-500.
7. Buzzi G, Poma M, Francese F, et al. Valutazione comparativa dell’efficacia dell’acido tioctico racemo e destrogiro nella lombosciatalgia. Analisi dei risultati dello studio clinico NESTIORADE. GIOT 2012; 38: 48-54.
8. Di Geronimo G, Caccese AF, Caruso L, et al. Treatment of carpal tunnel syndrome with alpha-lipoic acid. Eur Rev Med Pharmacol Sci 2009; 13: 133-9.
9. Han T, Bai J, Liu W, Hu Y. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol 2012; 167(4): 465-71
10. Lazzaro F, Traini E, Amenta F. Studio comparativo dell’efficacia di due antiossidanti contenenti acido tioctico nel trattamento della cervico-brachialgia e della lombo-cruro-sciatalgia. GIOT 2012; 38: 199-207.
11. Lazzaro F, Loiero M. Maggiore efficacia della terapia con acido lipoico enantiomero destrogiro rispetto alla forma racema alla dose di 600 mg/die per 8 settimane nella sindrome del tunnel carpale monolaterale. GIOT 2013; 39: 243-8.
12. Innocent NE, Amenta F, Di Cesare Mannelli L, et al. Thioctic acid enantiomers prevent central nervous system changes occurring in a model of compressive neuropathy. Italian Journal of Anatomy and Embryology 2011; 116(Suppl): 94.
13. Tomassoni D, Amenta F, Di Cesare Mannelli L, et al. Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury. Biomed Res Int 2013; 2013: 985093.
14. Lazzaro F. Studio comparativo sull’efficacia di Tendhyal nella tendinopatia achillea e nell’epicondilite. GIOT 2014; 40: 141-50.
15. Cameron M, Chrubasik S. Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev 2014; 5: CD002947.
16. Moussaieff A, Yu J, Zhu H, Gattoni-Celli S, Shohami E, Kindy MS. Protective effects of incensole acetate on cerebral ischemic injury. Brain Res 2012 Mar 14; 1443: 89-97.
17. ema 2007
18. Hüsch J, Bohnet J, Fricker G, et al. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extract. Fitoterapia 2013; 84: 89-98.
19. Lazzaro F, Loiero M. Confronto tra due schemi terapeutici con associazione di acido tioctico destrogiro e Boswellia serrata (Casperome®) nel trattamento delle radicolopatie compressive: efficacia di un trattamento prolungato con Destior® Bridge nella cervicobrachialgia e nella lombocrurosciatalgia. Giot 2015; 41: 80-9.